Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 680 participants.
Also called NCT07454980
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 680 participants
- Sponsor
- Jenscare Innovation Inc.
- Registry
-
NCT07454980
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT07454980. Randomized; single masking; primary purpose treatment. Start 2026-07-15 (actual); primary completion 2029-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)
- Condition
- Tricuspid Regurgitation (TR)
- Intervention (Device)
- TTVI with LuX-Valve Plus System
- Intervention (Device)
- TTVI with EVOQUE
- Lead sponsor
- Jenscare Innovation Inc.
Record details
- Record id
cardio:ct-nct07454980- Content hash
476cdd29470ce157cbb9f08874f685b1849f2739cd59bfd87a35d16aa75bdf56